Iatrogenic Drug Risk in People Over 75, With or Without Cognitive Disorders, From an Inventory of Their Family Pharmacy

Status

Withdrawn

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03686943

Acronym

RIMPAP

Enrollment

Registered

2018-09-27

Start date

2019-06-28

Completion date

2019-06-28

Last updated

2019-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elderly, Iatrogenic Drug Risk

Keywords

Elderly, Iatrogenic drug risk, Family pharmacy

Brief summary

Many hospitalizations or emergency room visits are due to problems of iatrogenic medication, especially in elderly patients who are very often polymedicated. Moreover, they are more at risk because of fragility. This has an important socio-economic impact. It therefore seems important to act upstream of these adverse events and a review of the drugs available in the homes of elderly patients seems a good starting point.

Interventions

OTHERFamily pharmacy

Observation of the family pharmacy in elderly group

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

75 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Patient over 75 years with or without cognitive disorders

Exclusion criteria

* Refusal to participate

Design outcomes

Primary

Measure	Time frame	Description
Iatrogenic drug risk in patients' homes	At the inclusion (baseline)	Description of potential drug contraindications and potential unadvisable drug interactions highlighted from the analysis of the family pharmacy by Theriaque databased

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026